TGen, Dell Spearhead Cancer Research
Dell will lend its computing muscle to TGen for a clinical trial that seeks to deliver treatments to children with a rare form of cancer.
Phoenix-based Translational Genomics Research Institute will evaluate the DNA of children with neuroblastoma, an often-fatal cancer that afflicts one in 100,000 children.
TGen will work with doctors treating children afflicted with the disease with the goal of developing tailored medical treatments.
More in: Noteworthy
